NASDAQ:UNCY | Profit Breakdown | Unicycive Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$10.14M-$1.72M
2026-03-31-$8.44M-$12.82M
2025-12-31-$7.22M-$14.67M
2025-09-30-$7.34M-$6.01M
2025-06-30-$6.96M-$6.45M
2025-03-31-$7.99M$570,000.00
2024-12-31-$9.26M-$21.53M
2024-09-30-$6.25M-$4.1M
2024-06-30-$7.4M$9.86M
2024-03-31-$9.2M-$20.96M
2023-12-31$0.00-$6.31M-$7.8M
2023-09-30-$5.94M-$4.33M
2023-06-30-$4.32M-$3.84M
2023-03-31$675,000.00-$4.2M-$14.58M
2022-12-31$0.00-$5.33M-$5.33M
2022-09-30$951,000.00-$5.55M-$5.56M
2022-06-30-$3.64M-$3.64M
2022-03-31-$3.54M-$3.54M
2021-12-31-$2.75M-$2.75M
2021-09-30-$4.72M-$5.2M
2021-06-30-$779,000.00-$1.1M
2021-03-31-$731,000.00-$964,000.00
2020-12-31-$717,000.00-$880,000.00
2020-09-30-$626,000.00-$702,000.00
2020-06-30-$336,000.00-$338,000.00
2020-03-31-$344,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$29.52M-$26.56M
2024-12-31-$32.12M-$36.73M
2023-12-31$675,000.00-$20.77M-$30.54M
2022-12-31$951,000.00-$18.05M-$18.06M
2021-12-31-$8.98M-$10.02M
2020-12-31-$2.02M-$2.26M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.